MMED Profile
- Sector: Health Technology
- Industry: Biotechnology
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Stanley D. Glick, and Jamon Alexander Rahn in 2019 and is headquarter in Toronto, Canada.
Recent News
MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders
Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disorders Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for …
Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic
Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to treat a mental health epidemic predicted …
- WeedMD Grants Deferred Share Units
- MediPharm Labs Announces Release of $18.9 Million in Escrowed Funds
- Innocan’s SHIR (TM) Beauty & Science CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union
- MJardin Group Announces Second Quarter 2020 Financial Results
- Green Thumb Industries and Cookies Enter Exclusive Partnership to Open Cookies on the Strip in Las Vegas
- Cronos Group Reports 2020 Second Quarter Results
- CannTrust Licenses Reinstated for Vaughan Manufacturing Facility
- Village Farms International to Host Second Quarter 2020 Conference Call on Thursday, August 13, 2020 at 8:30 a.m. ET
- Hollister Biosciences Inc. and Heavy Brands Inc. Enter into Letter of Intent for Proposed Joint Venture Agreement
- Acreage Announces Upcoming Conference Presentations
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.
[bbp-topic-index]